Gallic acid combined with anti-PD-1 antibody can block PD-L1/PD-1 signal transduction, downregulate Foxp3 stability, inhibit regulatory T cells, promote CD8 T cells to secrete IFN-γ, and limit CRC (167). The gene discussed is CD8A; the disease is colorectal carcinoma.